These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32145521)

  • 1. Initial deterioration and intravenous methylprednisolone therapy in patients with myasthenia gravis.
    Sugimoto T; Ochi K; Ishikawa R; Tazuma T; Hayashi M; Mine N; Naito H; Nomura E; Kohriyama T; Yamawaki T
    J Neurol Sci; 2020 May; 412():116740. PubMed ID: 32145521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of high-dose intravenous methylprednisolone therapy for ocular myasthenia gravis.
    Ozawa Y; Uzawa A; Kanai T; Oda F; Yasuda M; Kawaguchi N; Himuro K; Kuwabara S
    J Neurol Sci; 2019 Jul; 402():12-15. PubMed ID: 31100651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness and safety of intravenous methylprednisolone and tacrolimus monotherapy in ocular myasthenia gravis with unsatisfactory prednisone responses: a retrospective study.
    Zhang KY; Duan WW; Luo YB; Li Y; Hu J; Yang H
    Orphanet J Rare Dis; 2024 Jan; 19(1):19. PubMed ID: 38243274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia Gravis.
    Uzawa A; Suzuki S; Kuwabara S; Akamine H; Onishi Y; Yasuda M; Ozawa Y; Kawaguchi N; Kubota T; Takahashi MP; Suzuki Y; Watanabe G; Kimura T; Sugimoto T; Samukawa M; Minami N; Masuda M; Konno S; Nagane Y; Utsugisawa K
    Neurotherapeutics; 2023 Mar; 20(2):518-523. PubMed ID: 36607596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of myasthenia gravis with methylprednisolone pulse: a double blind study.
    Lindberg C; Andersen O; Lefvert AK
    Acta Neurol Scand; 1998 Jun; 97(6):370-3. PubMed ID: 9669469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
    Howard JF; Utsugisawa K; Benatar M; Murai H; Barohn RJ; Illa I; Jacob S; Vissing J; Burns TM; Kissel JT; Muppidi S; Nowak RJ; O'Brien F; Wang JJ; Mantegazza R;
    Lancet Neurol; 2017 Dec; 16(12):976-986. PubMed ID: 29066163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized Trial of Thymectomy in Myasthenia Gravis.
    Wolfe GI; Kaminski HJ; Aban IB; Minisman G; Kuo HC; Marx A; Ströbel P; Mazia C; Oger J; Cea JG; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BR; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Garcia Ramos GS; Verschuuren JJ; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Conwit R; Odenkirchen J; Sonett JR; Jaretzki A; Newsom-Davis J; Cutter GR;
    N Engl J Med; 2016 Aug; 375(6):511-22. PubMed ID: 27509100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymectomy in myasthenia gravis: proposal for a predictive score of postoperative myasthenic crisis.
    Leuzzi G; Meacci E; Cusumano G; Cesario A; Chiappetta M; Dall'armi V; Evoli A; Costa R; Lococo F; Primieri P; Margaritora S; Granone P
    Eur J Cardiothorac Surg; 2014 Apr; 45(4):e76-88; discussion e88. PubMed ID: 24525106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of postoperative myasthenic crisis in patients with myasthenia gravis after thymectomy.
    Chu XY; Xue ZQ; Wang RW; Tan QY
    Chin Med J (Engl); 2011 Apr; 124(8):1246-50. PubMed ID: 21543005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for the clinical guidelines for myasthenia gravis in Japan.
    Murai H; Utsugisawa K; Nagane Y; Suzuki S; Imai T; Motomura M
    Ann N Y Acad Sci; 2018 Feb; 1413(1):35-40. PubMed ID: 29377151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis?
    Sekine Y; Kawaguchi N; Hamada C; Sekiguchi H; Yasufuku K; Iyoda A; Shibuya K; Fujisawa T
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):908-13. PubMed ID: 16675232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical thymectomy in the treatment of myasthenia gravis.
    Donnelly RJ; Laquaglia MP; Fabri B; Hayward M; Florence AM
    Ann R Coll Surg Engl; 1984 Sep; 66(5):305-8. PubMed ID: 6486664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study.
    McPherson T; Aban I; Duda PW; Farzaneh-Far R; Wolfe GI; Kaminski HJ; Cutter G; Lee I;
    Muscle Nerve; 2020 Aug; 62(2):261-266. PubMed ID: 32369631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up after robotic thymectomy for nonthymomatous myasthenia gravis.
    Freeman RK; Ascioti AJ; Van Woerkom JM; Vyverberg A; Robison RJ
    Ann Thorac Surg; 2011 Sep; 92(3):1018-22; discussion 1022-3. PubMed ID: 21871293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QMG and MG-ADL correlations: Study of eculizumab treatment of myasthenia gravis.
    Howard JF; Freimer M; O'Brien F; Wang JJ; Collins SR; Kissel JT;
    Muscle Nerve; 2017 Aug; 56(2):328-330. PubMed ID: 28010051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraocular muscle responses to high dose intravenous methylprednisolone in myasthenia gravis.
    Komiyama A; Arai H; Kijima M; Hirayama K
    J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):214-7. PubMed ID: 10644791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of thymectomy in myasthenia gravis patients with thymus hyperplasia.
    Yang J; Liu C; Li T; Li C
    Int J Neurosci; 2017 Sep; 127(9):785-789. PubMed ID: 27819773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of myasthenic crisis after thymectomy for thymoma patients with myasthenia gravis.
    Xue L; Wang L; Dong J; Yuan Y; Fan H; Zhang Y; Wang Q; Ding J
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):692-697. PubMed ID: 29156018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous neostigmine infusion in post-thymectomy juvenile myasthenic crisis.
    Briassoulis G; Hatzis T; Liakopoulou T; Youroukos S
    J Child Neurol; 2000 Nov; 15(11):747-9. PubMed ID: 11108508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved outcomes with early immunosuppression in patients with immune-checkpoint inhibitor induced myasthenia gravis, myocarditis and myositis: a case series.
    Weaver JM; Dodd K; Knight T; Chaudhri M; Khera R; Lilleker JB; Roberts M; Lorigan P; Cooksley T
    Support Care Cancer; 2023 Aug; 31(9):518. PubMed ID: 37572133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.